RESOURCE LIBRARY

Resources from Amgen

Lipid Regulation and Atherosclerosis

The Role of PCSK9 in the Regulation of LDL-C

Watch the video below, which gives an overview of the role of PCSK9 in cholesterol homeostasis through regulation of low-density lipoprotein receptor (LDLR) degradation.

Associated materials

View the video below and download the associated materials relating to the role of PCSK9 in the regulation of LDL-C here.

interactive

Gain-of-function

Loss-of-function

Atherosclerotic Plaque Vulnerability

View this interactive artery showing the progression of atherosclerosis and plaque vulnerability.

interactive-array-img

Cholesterol Heat Map

Do you know the low-density lipoprotein cholesterol LDL-C levels of patients with high-risk CVD in your area? View this Cholesterol Heat.

heat-map

Optimizing Lipid Management

Video: How Have Cholesterol Guidelines Changed?

Watch how LDL-C levels recommended by multiple ccholesterol guidelines have decreased over time and understand current recommendations for patients with very high-risk ASCVD..

Podcast: Why It’s Time to Reassess LDL-C Goals

Learn how you can better manage cholesterol in patients with high-risk ACS and help reduce the risk of subsequent cardiovascular events.


Webinar: Guidelines, Discharge Protocol, and Routine Follow-up to Optimize Treatment in Patients With Recent MI

Watch experts discuss current cholesterol guidelines, discharge protocol, and routine follow-up in patients with recent MI.

Webinar: Optimizing HCP/Patient Conversation about the Importance of LDL-C Lowering for Patients With Recent MI

Watch experts discuss the HCP/patient conversation regarding the importance of LDL-C lowering for patients with recent MI.

Additional Resources – Clinical Practice Recommendations

AHA/ACC/Multisociety 2018 Guideline

Click here to view the American College of Cardiology/American Heart Association Task Force guidelines for the management of blood cholesterol.

ESC/EAS 2019 Guidelines

Click here to view the 2019 European Society of Cardiology and European Atherosclerosis Society Task Force guidelines for the management of dyslipidemia.

AACE/ACE 2020 Algorithm

Click here to view the American Association of Clinical Endocrinologists and American College of Endocrinology Guidelines for the management of dyslipidemia and prevention of CVD.

2022 ACC Expert Consensus

Click here to view the American College of Cardiology's ECDP guidance on the role of non-statin therapies for LDL-C lowering in the management of ASCVD risk.

Additional Educational Resources

PDF: The Science and Clinical Management of ASCVD

Download this overview that explains the scientific progression of atherosclerosis and ASCVD, and includes recent clinical guidelines for the treatment of patients with very high-risk ASCVD.